Volunteering for a monoclonal antibody COVID19 clinical trial
It must be stressed that this is of course still an experimental treatment, although there is clearly a lot of emerging evidence that antibodies are important in fighting COVID19. So there is a reasonable hope that recipients of this treatment like this will most likely experience at least some degree of protection from the COVID19 virus which is not dependent on their own immune system.
